Follow
Elias H. Augestad
Elias H. Augestad
Unknown affiliation
Verified email at stud.ntnu.no
Title
Cited by
Cited by
Year
Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies
N Tzarum, E Giang, L Kong, L He, J Prentoe, E Augestad, Y Hua, ...
Science Advances 5 (1), eaav1882, 2019
782019
Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations
J Prentoe, R Velázquez-Moctezuma, EH Augestad, A Galli, R Wang, ...
Proceedings of the National Academy of Sciences 116 (20), 10039-10047, 2019
502019
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity
EH Augestad, M Castelli, N Clementi, LJ Ströh, T Krey, R Burioni, ...
Science Advances 6 (35), eabb5938, 2020
34*2020
An alternate conformation of HCV E2 neutralizing face as an additional vaccine target
N Tzarum, E Giang, RU Kadam, F Chen, K Nagy, EH Augestad, ...
Science advances 6 (30), eabb5642, 2020
262020
Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
F Chen, N Tzarum, X Lin, E Giang, R Velázquez-Moctezuma, ...
Immunity 54 (4), 781-796. e4, 2021
252021
Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1
EH Augestad, J Bukh, J Prentoe
Current opinion in virology 50, 69-75, 2021
132021
Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice
AF Pihl, S Feng, A Offersgaard, GP Alzua, EH Augestad, CK Mathiesen, ...
Journal of Hepatology 76 (5), 1051-1061, 2022
112022
Mechanisms of hepatitis C virus escape from vaccine-relevant neutralizing antibodies
R Velázquez-Moctezuma, EH Augestad, M Castelli, C Holmboe Olesen, ...
Vaccines 9 (3), 291, 2021
102021
Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies. Sci Adv 5: eaav1882
N Tzarum, E Giang, L Kong, L He, J Prentoe, E Augestad, Y Hua, ...
72019
Identification of novel neutralizing determinants for protection against HCV
GP Alzua, AF Pihl, A Offersgaard, R Velázquez‐Moctezuma, ...
Hepatology 77 (3), 982-996, 2023
42023
Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens
J Prentoe, CM Janitzek, R Velázquez-Moctezuma, L Goksøyr, RW Olsen, ...
Plos one 16 (7), e0255336, 2021
42021
In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus
CH Olesen, EH Augestad, F Troise, J Bukh, J Prentoe
PLoS Pathogens 17 (7), e1009720, 2021
42021
Structure of the hepatitis C virus E1/E2 envelope proteins in a homodimeric complex
E Augestad, CH Olesen, C Groenberg, A Soerensen, ...
bioRxiv, 2023.12. 27.573427, 2023
2023
Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens
L Goksøyr, RW Olsen, M Fanalista, EH Augestad, S Thrane, AF Pihl, ...
2021
In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus
EH Augestad, F Troise, J Prentoe
2021
Identification of Novel Determinants of Neutralization Epitope Shielding for Hepatitis C Virus in Vitro
GP Alzua, AF Pihl, AF Offersgaard, R Velázquez-Moctezuma, ...
Proceedings 50 (1), 5, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–16